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PLVH and Arrhythmias
pectrum and Prognostic Significance
f Arrhythmias on Ambulatory Holter
lectrocardiogram in Hypertrophic Cardiomyopathy
. Selcuk Adabag, MD,* Susan A. Casey, RN,† Michael A. Kuskowski, PHD,* Andrey G. Zenovich, MSC,†
arry J. Maron, MD, FACC†
inneapolis, Minnesota
OBJECTIVES The goal of this study was to assemble a profile and assess the significance of arrhythmias in
a nontertiary-based hypertrophic cardiomyopathy (HCM) cohort.
BACKGROUND Hypertrophic cardiomyopathy is associated with arrhythmia-related consequences, particu-
larly sudden death. Ventricular tachyarrhythmias on Holter electrocardiograms (ECG) have
been reported as markers for sudden death in highly selected HCM populations.
METHODS We assessed the profile of ventricular and supraventricular ectopy and bradyarrhythmia on
ambulatory 24-h Holter ECG and also related these findings to clinical outcome in 178
HCM patients.
RESULTS Of the 178 study patients, 157 (88%) had premature ventricular complexes (PVCs), including
21 (12%) with500 PVCs, 74 (42%) had couplets, 67 (37%) had supraventricular tachycardia
(SVT), and 56 (31%) had nonsustained ventricular tachycardia (NSVT). Mean number of
PVCs was 330  763 (range 1 to 5,435) and increased with age (p  0.01); NSVT was
associated with greater left ventricular hypertrophy (p  0.01) and severe symptoms (New
York Heart Association functional classes III and IV) (p  0.04); SVT occurred more
commonly in patients with outflow obstruction (p  0.02). Over a follow-up of 5.5  3.4
years, 11 (6%) patients died suddenly (annual mortality rate, 1.1%) including 5 patients with
NSVT. For sudden death, NSVT on Holter ECG had negative and positive predictive values
of 95% and 9%, and sensitivity and specificity of 45% and 69%, respectively.
CONCLUSIONS In this nontertiary-based HCM cohort, ventricular and supraventricular tachyarrhythmias
were particularly frequent and demonstrated a broad spectrum on ambulatory (Holter) ECG.
Paradoxically, despite such a highly arrhythmogenic substrate, sudden death events proved to
be relatively uncommon. Ventricular tachyarrhythmias had a low positive and relatively high
negative predictive value for sudden death in this HCM population. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.11.0432005;45:697–704) © 2005 by the American College of Cardiology Foundation
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typertrophic cardiomyopathy (HCM) is a primary myo-
ardial disease associated with a risk for sudden death as a
irect consequence of ventricular tachyarrhythmias (1–9).
ndeed, HCM is the most common cause of sudden cardiac
eath in young people, including trained athletes (2,10–18).
Ambulatory Holter electrocardiography (ECG) has been
sed extensively in the evaluation and risk stratification of
CM patients (19–24). Previously, in HCM cohorts from
ertiary care centers with a disproportionate representation
f high-risk patients, nonsustained ventricular tachycardia
NSVT) on 24- to 48-h ambulatory ECG proved to be
redictive of future events (20,21,24). However, arrhythmia
rofile (and its prognostic significance) in less selected
CM cohorts that are closest to the true disease state in the
ommunity remains unresolved and is the focus of this
nvestigation.
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enter, Veterans Affairs Medical Center, Minneapolis, Minnesota; and the †Hyper-
rophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minne-
polis, Minnesota.a
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election and demographics of study patients. Between
975 and 2001, 535 patients with HCM were evaluated at
he Minneapolis Heart Institute, a large community-based
linic and hospital service primarily supporting the Minne-
polis and St. Paul metropolitan area (population, 3 million)
nd the state of Minnesota (population, 5 million) (2–4).
f these, 296 patients from the five-state Upper Midwest
egion (Minnesota and the contiguous states of Wisconsin,
owa, North Dakota, and South Dakota), not subject to
ertiary center referral, were initially included in the study
roup. None of these patients had been selectively referred
o our institution for specialized care of HCM. The other
39 HCM patients evaluated at our institution since 1994,
ho were preferentially referred to the senior author
B.J.M.) for specialized care related to HCM (in the context
f tertiary referral) were excluded from the present cohort.
atients in this study were initially referred for cardiac
ymptoms (e.g., dyspnea or chest pain), findings on physical
xamination (e.g., heart murmur), abnormal ECG, evalua-
ion of other cardiac diseases (e.g., coronary artery disease), or
cute cardiovascular events (e.g., syncope, atrial fibrillation).
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Holter ECG in HCM March 1, 2005:697–704Of the 296 HCM patients, 178 were identified as having
t least one 24-h ambulatory (Holter) ECG recording (Fig.
). These studies were obtained on a routine clinical basis by
he participating cardiologists at our institution, and con-
titute the present study group. Although Holter ECGs are
art of our standard outpatient evaluation for the risk
tratification of HCM patients, it was not our general
ractice to routinely obtain these recordings in children and
he older patients (i.e., ages 20 years and 50 years).
onsequently, 82% (n  97) of the 118 patients without a
olter ECG were in these age groups.
At study entry, the 178 HCM study patients ranged in
ge from 5 to 89 years (mean 50  18 years) and 101 (57%)
ere male. Of the 178 patients, 84 (48%) were in New York
eart Association (NYHA) functional class I, 61 (34%)
ere class II, and 32 (18%) were severely symptomatic in
lasses III/IV. Thirty-nine (22%) patients had a left ven-
ricular (LV) outflow gradient of 30 mm Hg under basal
onditions. Follow-up period extended from the time of the
olter ECG recording to June 2001, or when death
ccurred, and ranged from 1 to 22 years (mean 5.5  3.4
ears) (Table 1). At the time of the Holter recording, 119
66%) patients were taking one or more of a variety of
ardioactive medications: beta-adrenergic receptor blockers
n  79), verapamil (n  52), disopyramide (n  7), and
miodarone (n  4). Twenty-two patients (12%) had
ardioverter defibrillator implanted prophylactically.
efinitions. Diagnosis of HCM was based on the echo-
ardiographic demonstration of a hypertrophied (defined as
wall thickness 13 mm in adult patients or the equivalent
all thickness relative to body surface area in children)
Abbreviations and Acronyms
AV  atrioventricular
HCM  hypertrophic cardiomyopathy
LV  left ventricle/ventricular
NSVT  nonsustained ventricular tachycardia
NYHA  New York Heart Association
PVC  premature ventricular complex
SVT  supraventricular tachycardia
igure 1. Flow diagram showing the clinical outcome of 178 patients withf
ypertrophic cardiomyopathy (HCM) who underwent 24-h ambulatory
Holter) electrocardiogram monitoring. HF  heart failure.ondilated LV in the absence of another cardiac or systemic
isease that could produce the magnitude of hypertrophy
vident in that patient (25,26); NSVT and supraventricular
achycardia (SVT) were defined as three or more consecu-
ive premature complexes with a heart rate100 beats/min.
ouplets were two consecutive premature ventricular com-
lexes (PVCs). Sinus bradycardia was defined as an average
eart rate 60 beats/min during the 24-h monitoring
eriod.
Sudden cardiac death was defined as unexpected sudden
ollapse occurring 1 h from the onset of symptoms in a
atient who had previously experienced a relatively stable or
neventful clinical course. Unwitnessed death was also
lassified as sudden if it occurred unexpectedly (e.g., at
ight, in a patient without prior severe symptoms). In
ddition, potentially lethal cardiovascular events in which 3
atients either were successfully resuscitated from cardiac
rrest (n  1) or received appropriate shocks from an
mplanted cardioverter-defibrillator (n  2) were regarded
s equivalents of sudden cardiac death in the present data
nalysis (3).
mbulatory Holter ECGs. Ambulatory Holter ECG re-
ordings were obtained in a standard fashion with a portable
ape recorder and modified V1 and V5 leads. Holter ECG
ecordings were scanned on a DelMar Reynolds AccuPlus
model 363) Holter Analysis System (Del Mar Reynolds
edical, Irvine, California), which utilizes technician inter-
ction in arrhythmia analysis aided by visual superimposi-
ion to correct for artifact and any erroneous analysis. In
ach case the arrhythmias were verified by an experienced
ardiologist who was blinded to the clinical, echocardio-
raphic, and follow-up data. Arrhythmia frequency was
ormalized to 24 h for recordings, which did not include a
able 1. Demographics and the Clinical Profile of 178 HCM
atients With 24-h Ambulatory ECG
ge (yrs) 50  18
ale gender 101 (57%)
YHA functional class
I 84 (48%)
II 61 (34%)
III/IV 32 (18%)
V outflow obstruction at rest 30 mm Hg 39 (22%)
aximal LV wall thickness (mm)
15 11 (6%)
16–19 46 (26%)
20–24 81 (45%)
25–29 19 (11%)
30 21 (12%)
eft atrial size (mm) 43  9
V end-diastolic diameter (mm) 44  7
rugs
Beta-blocker 80 (45%)
Calcium channel blocker 52 (29%)
Disopyramide 7 (4%)
Amiodarone 4 (2%)
ollow-up from Holter recording (yrs) 5.5  3.4
CG  electrocardiography; HCM  hypertropic cardiomyopathy; LV  left
entricular; NYHA  New York Heart Association.ull 24-h of interpretable rhythm due to noise or loss of
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March 1, 2005:697–704 Holter ECG in HCMignal. In those patients with 1 ambulatory Holter ECG,
he recording with the most substantial ectopy (i.e., the
ighest frequency of either NSVT, couplets, or PVCs) was
ncluded in the data analysis.
chocardiography. Echocardiographic studies were per-
ormed with commercially available Hewlett-Packard in-
truments. Greatest thickness measured at any site in the
V wall was considered as the maximal thickness (27). Peak
nstantaneous LV outflow gradient was estimated with
ontinuous-wave Doppler (28).
tatistical methods. Data are presented as mean values 
D. Categorical data were analyzed using chi-square test.
utcome variables were compared between groups using t
ests (or Mann-Whitney U tests when not normally distrib-
ted). Relationships between arrhythmia occurrence and
requency and demographic variables were assessed with
earson correlation coefficients (or Spearman correlation
oefficients when not normally distributed). Distributional
ormality was assessed using the Lilliefors test. Odds ratios
or predicting sudden death were obtained by logistic
egression. A p value of 0.05 was taken as statistically
ignificant.
For each individual study patient and the overall study
roup, the number of PVCs, couplets, and NSVT runs that
ccurred in each hour of the day was tabulated separately. The
resence of a diurnal pattern was assessed using a Poisson
egression model with logarithmic link function. The
ENMOD procedure in SAS software (version 8.1, SAS
nstitute Inc., Cary, North Carolina) was applied. The
epeated occurrence of arrhythmias within a given patient
as taken into account in the analysis. The expected
umber of episodes was modeled as a linear combination of
igure 2. Prevalence of ventricular and supraventricular arrhythmias on
ypertrophic cardiomyopathy. NSVT nonsustained ventricular tachycardine and cosine functions with 1, 2, 3, or 4 cycles in 24 h.
c
Phe cycles that did not contribute to the model were
equentially eliminated (29).
ESULTS
entricular tachyarrhythmias. PVCS. Of the 178 study
atients, 157 (88%) had 1 PVC (range 1 to 5,435; mean
30  763) including 40 (22%) with 200 PVCs and 21
12%) with 500 PVCs (Fig. 2); PVCs were multifocal in
10 patients and unifocal in 47 patients. The number of
VCs increased with age (Spearman rho  0.32, p  0.01)
Fig. 3).
OUPLETS. Seventy-four (42%) patients had couplets (range 1
o 549; mean 24 78). Occurrence of couplets correlated with
ambulatory (Holter) electrocardiogram recording in 178 patients with
C premature ventricular complex; SVT supraventricular tachycardia.
igure 3. Relation between age at 24-h ambulatory (Holter) electrocar-
iogram (ECG) monitoring and the number of premature ventricular24-h
ia; PVomplexes (PVCs) in the 157 hypertrophic cardiomyopathy patients with
VCs.
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Holter ECG in HCM March 1, 2005:697–704lder age (p  0.002) and advanced symptoms (NYHA
unctional classes III or IV) (p  0.05) (Fig. 4).
SVT. Fifty-six (31%) patients had runs of NSVT (range 1
o 115; mean 6 17) including 18 (10%) with3 runs, and
2 (7%) with 5 runs. Bursts of NSVT ranged in length
rom 3 to 26 beats/min (mean 6 beats/min) at an average
ate of 150 beats/min; NSVT also occurred more commonly
n patients with advanced symptoms (NYHA functional
lasses III or IV) (chi-square, p  0.04) (Fig. 4). Of the 56
atients with NSVT runs, only 2 (3%) of patients reported
alpitations during the arrhythmia, and none had syncope.
lso, there was no association between occurrence of NSVT
nd prior syncopal episodes.
REQUENT AND/OR COMPLEX ARRHYTHMIAS. Of the 178
tudy patients, 97 (54%) had complex ventricular arrhyth-
ias on 24-h Holter, including couplets, NSVT, or both.
ighty patients (45%) were judged to have particularly
requent or complex ventricular arrhythmia consisting of1
SVT run or5 couplets or200 PVCs. Of note, 16 (9%)
ad all 3 of these arrhythmias: 1 NSVT and 5 couplets
nd 200 PVCs (Fig. 2). Patients who had 1 PVC were
igure 4. Relation of symptom severity (top panel) and left ventricular
utflow obstruction (bottom panel) with the occurrence of arrhythmias on
4-h ambulatory (Holter) electrocardiogram monitoring in 178 hypertro-
hic cardiomyopathy patients. AF  atrial fibrillation; LVOTG  left
entricular outflow tract gradient; NSVT  nonsustained ventricular
achycardia; NYHA  New York Heart Association; PVC  premature
entricular complex; SVT  supraventricular tachycardia.ore likely to have couplets (p  0.0001). Similarly, 5atients who had couplets were more likely to have NSVT
p  0.001).
IURNAL VARIABILITY. Nonsustained ventricular tachycar-
ia occurred in a circadian pattern with a peak at 8 AM and
trough at 11 PM (p  0.001), while the couplets showed
wo peaks at 2 AM and 2 PM and troughs at 6 AM and 6 PM
p  0.01). A circadian distribution was not identified for
VCs.
RUGS. Number of PVCs, couplets, or NSVT was not
elated to whether or not cardioactive drugs were taken by
atients at the time of the Holter ECG. For example, PVCs
ccurred in 99 of the 116 patients (85%) who were taking
eta-adrenergic or calcium channel blockers compared with
7 of the 59 patients (96%) who were not taking drugs (p
S). Similarly, NSVT occurred no more frequently in
atients who were taking beta-adrenergic or calcium chan-
el blockers compared with those not taking drugs (37 of
16; 32% vs. 19 of 59; 32%; p  NS).
upraventricular tachyarrhythmias. Of the 178 study pa-
ients, 67 (38%) had runs of SVT (range 1 to 557; mean 16
71), including 32 patients (18%) with 3 runs and 24
atients (13%) with5. Bursts of SVT ranged from 3 to 93
eats/min (mean 12 beats/min) with an average rate of 134
eats/min; SVT was significantly more common in older
atients (p  0.0001) and patients with LV outflow
bstruction (gradient 30 mm Hg at rest) (p  0.02) (Fig.
). Atrial fibrillation was detected in 16 (9%) of the 178
atients, and its occurrence correlated with older age (p 
.004), advanced symptoms (NYHA functional classes III
r IV) (p  0.0001) (Fig. 4), and enlarged left atrium (p 
.0001).
radyarrhythmias. Of the 178 patients, 25 (14%) had
vidence of sinus bradycardia (average heart rate 60
eats/min in 24 h). Patients with sinus bradycardia had
ignificantly less frequent PVCs than those patients with
verage heart rate60 beats/min (42 72 PVCs vs. 392
19 PVCs, respectively; Mann-Whitney test, p  0.004).
onduction abnormalities. Forty-one patients (23%) had
1 conduction abnormalities. Specifically, 31 (17%) had
rst degree atrioventricular (AV) block, 6 (3%) had second
egree AV block, and 12 (7%) had sinus pauses 2 s.
elation of arrhythmias to LV hypertrophy. Left ventric-
lar wall thickness was significantly greater in patients with
SVT (23.2 5.7 mm) than those without NSVT (21.3
.9 mm, p  0.01), and the likelihood of NSVT increased
ith respect to greater LV wall thickness (Pearson correla-
ion, p  0.02) (Fig. 5). Also, NSVT was more common in
atients with extreme LV hypertrophy (wall thickness 30
m) than in patients with mild hypertrophy (wall thickness
20 mm) (11 of 21; 52% vs. 9 of 57; 16%, respectively; p 
.01). Conversely, SVT was less common in patients with
xtreme hypertrophy compared with other patients (p 
.001) (Fig. 5).
elation of ventricular arrhythmia to outcome. Over the
.5  3.4 year follow-up period, 15 (8%) of the 178 study
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March 1, 2005:697–704 Holter ECG in HCMatients died of HCM-related causes, including 11 (6%)
uddenly and 4 (2%) of heart failure or stroke (Fig. 1). Other
eaths included 6 patients (3%) of coronary heart disease
nd 16 (9%) of noncardiac or unknown causes. Total
ortality, HCM-related mortality, and HCM-related sud-
en death were 3.8%, 1.4%, and 1.1% per year, respectively.
oreover, the estimated rate for sudden death was 1.8% per
ear in patients with NSVT on Holter ECG, compared
ith 0.8% per year in those without NSVT.
Patients with sudden death, all HCM-related deaths, and
urvivors were compared with respect to several demo-
raphic or arrhythmia parameters (Table 2). There were no
ignificant differences between patients who died suddenly
nd the survivors with regard to arrhythmia profile on 24-h
olter ECG. Although odds ratio for sudden death by
ogistic regression was 1.9 (95% confidence interval: 0.5 to
.5) in patients with NSVT and 2.4 (95% confidence
nterval: 0.5 to 12.4) in patients with combined NSVT and
5 couplets and 200 PVCs, neither of these associations
chieved statistical significance (p  0.05). However, those
atients who died of all HCM-related causes (including
udden death) had greater numbers of PVCs (p  0.05)
hen compared with survivors (Table 2).
Predictive values, sensitivity, and specificity of ventricular
igure 5. Relation between maximum left ventricular (LV) wall thickne
lectrocardiogram recording in 178 hypertrophic cardiomyopathy patients
irect relation to maximal LV thickness (p  0.02 by the chi-square test fo
aximal LV thickness 30 mm vs. 30 mm (p  0.001). PVCs  premrrhythmias on Holter for predicting sudden death (Table p) consistently showed low positive predictive value and a
igh negative predictive value. For example, NSVT on
olter had 9% positive predictive value and 95% negative
redictive value, as well as 45% sensitivity and 69% speci-
city (Table 3).
ISCUSSION
he present study demonstrates a broad spectrum of ven-
ricular and supraventricular arrhythmias occurring with
articular frequency on ambulatory (Holter) ECG in a
ontertiary-based, low-risk HCM cohort. For example,
lmost 90% of our patients had PVCs with an average of
300 per patient in 24 h of ECG recording (ranging up to
5,000). More than one-half of the cohort showed complex
entricular arrhythmias in the form of couplets, NSVT, or
oth. Furthermore, almost one-half of the patients had a
ombination of frequent and/or complex arrhythmia with
SVT or 5 couplets or 200 PVCs. Of particular note,
SVT occurred with similar frequency in our relatively
ow-risk and nontertiary-based cohort as in previously
eported tertiary center HCM populations disproportion-
tely comprised of high-risk patients (20,21,24). For exam-
d occurrence of various tachyarrhythmias on 24-h ambulatory (Holter)
sustained ventricular tachycardia (NSVT) increased progressively and in
d). Supraventricular tachycardia (SVT) was less common in patients with
ventricular complexes.ss an
. Nonle, in selectively referred cohorts (20,21,24), NSVT was
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Holter ECG in HCM March 1, 2005:697–704dentified on Holter ECG in 20% to 30% of patients
ompared with about 30% in our patient population.
However, despite the high prevalence of frequent and/or
omplex tachyarrhythmias in our population, sudden deaths
s well as all HCM-related deaths (1.1% per year and 1.4%
er year, respectively) were uncommon, demonstrating a
ismatch between the arrhythmogenic substrate and out-
ome. Of note, our HCM mortality rates are substantially
ower than the 3% to 6% per year previously reported from
ertiary-referred HCM cohorts (2,10,14) but are consistent
ith reports from other less-selected HCM populations
imilar to the present cohort (3,22,23). On the other hand,
he rate of sudden death in our study cohort was 10-fold and
00-fold higher than that in the general population for
dults and children, respectively (i.e., 0.1% per year for
dults; 0.01% per year for children) (30).
In other respects, the presence of arrhythmias on 24-h
olter appeared to be a manifestation of severe disease
xpression. For example, NSVT and couplets were more
able 2. Comparison of Clinical Outcome, Demographic Variabl
n 178 HCM Patients
HCM-Related
Sudden Death
(n  11)
All H
Related
(n 
ge at Holter 48  19 52 
ale gender 4 (36%) 5 (
YHA functional class I–II 7 (64%) 8 (
V outflow gradient 30 mm Hg 3 (27%) 5 (
aximal LV wall thickness (mm) 26.7  7.7 25.6 
1 NSVT (n  56) 5 (45%) 7 (
1 couplet (n  74) 5 (45%) 6 (
1 PVC (n  157) 8 (73%) 11 (
1 SVT (n  67) 2 (18%) 4 (
trial fibrillation (n  16) 1 (9%) 1 (
5 couplets (n  26) 3 (27%) 4 (
3 NSVT (n  18) 2 (18%) 3 (
200 PVCs (n  40) 3 (27%) 4 (
500 PVCs (n  21) 2 (18%) 2 (
V block 1 (9%) 3 (
radycardia 0 1 (
o. of PVCs 520  880 431 
o. of couplets 10  10 10 
o. of NSVT runs 2.5  1.7 3.3 
SVT length (beats) 7  2.6 7.3 
SVT rate (beats/min) 176  43.7 166 
V atrioventricular; HCM hypertrophic cardiomyopathy; LV left ventricular;
eart Association; PVC  premature ventricular complex; SVT  supraventricular
Table 3. Sensitivity, Specificity, and Predictive
Ambulatory ECG as Predictors of Sudden De
Sensitivity Sp
1 NSVT 45%
1 couplet 45%
1 PVC 73%
3 NSVT 18%
500 PVCs 18%
1 NSVT or 1 couplet 64%HCM  hypertrophic cardiomyopathy; NSVT  nonsustained venommon in HCM patients with advanced symptoms
NYHA functional classes III or IV), and NSVT was
ignificantly more common in association with extreme LV
ypertrophy (31). The latter finding is relevant to recent
bservations that relate extreme LV hypertrophy to a greater
ikelihood of sudden death in HCM (14,27,32). Moreover,
he circadian distribution for NSVT with a midmorning
eak demonstrated here, coincided with the previously
eported diurnal pattern of sudden cardiac death in HCM
33). However, the significance and biological basis for the
ircadian pattern we observed for couplets is uncertain. In
ddition, bradyarrhythmias were uncommon (15%), not
inked to demographic variables or clinical outcome, and
ere associated only with infrequent PVCs.
In the present relatively low-risk HCM cohort, the odds
atio and annual mortality rate for sudden death in patients
ith NSVT on Holter ECG was about two times that of
atients without NSVT. However, these associations did
ot achieve statistical significance, largely due to the low
nd Arrhythmia Profile on 24-h Ambulatory ECG Monitoring
-
th Survivors
(n  141)
p Value
Sudden Death
vs. Survivors
p Value
Any HCM Deaths
vs. Survivors
48  18 NS NS
85 (60%) NS 0.04
122 (87%) 0.03 0.001
28 (20%) NS NS
21.7  5 0.01 0.02
38 (27%) NS NS
60 (43%) NS NS
128 (91%) NS NS
55 (39%) NS NS
9 (6%) NS NS
17 (12%) NS NS
10 (7%) NS NS
29 (21%) NS NS
14 (10%) NS NS
24 (17%) NS NS
20 (14%) NS NS
263  620 NS 0.05
22  83 NS NS
4.3  10 NS NS
5.8  4.5 NS NS
153  27 NS NS
not significant; NSVT nonsustained ventricular tachycardia; NYHA New York
ardia.
e of Ventricular Arrhythmias on 24-h
HCM
ity
Positive
Predictive Value
Negative
Predictive Value
9% 95%
7% 94%
5% 86%
11% 94%
10% 94%
7% 95%es, a
CM
Dea
15)
20
33%)
53%)
33%)
7
47%)
40%)
73%)
27%)
7%)
27%)
20%)
27%)
13%)
20%)
7%)
759
9
2.2
3.8
36Valu
ath in
ecific
69%
59%
11%
90%
89%
46%tricular tachycardia; PVC  premature ventricular complex.
e
f
f
d
t
o
t
c
s
a
l
b
s
b
l
s
E
c
t
v
p
d
p
h
fi
r
S
i
t
s
o
i
s
H
a
r
o
t
c
r
1
t
o
e
I
p
c
c
m
t
h
t
s
H
w
r
s
f
p
H
H
a
(
v
e
R
V
1
a
R
1
1
1
1
1
1
1
1
703JACC Vol. 45, No. 5, 2005 Adabag et al.
March 1, 2005:697–704 Holter ECG in HCMvent rate in our study population. Similarly, an earlier study
rom a low-risk HCM population also showed a relative risk
or sudden death of 2 in patients with NSVT (which also
id not achieve statistical significance) (22). Therefore, in
his regard our findings are, in fact, consistent with previ-
usly reported data.
On the other hand, three other studies from higher risk
ertiary-based HCM cohorts reported statistically signifi-
ant relationships between NSVT on Holter ECG and
udden death (20,21,24). We believe that if our cohort had
higher event rate, larger sample size, or was followed for a
onger period of time, it is likely that the association
etween NSVT and sudden death may well have achieved
tatistical power. Indeed, it is possible that nontertiary-
ased HCM cohorts (such as the present one) implicitly
ack the statistical power to unequivocally demonstrate a
ignificant relationship between arrhythmias on Holter
CG and outcome.
The ambulatory Holter ECG has been an important
omponent of the outpatient evaluation and risk stratifica-
ion of HCM patients (19–24). In the present study,
entricular arrhythmias on ambulatory Holter showed low
ositive and high negative predictive values for sudden
eath (9% and 95%, respectively). Therefore, while the
resence of these arrhythmias did not consistently identify
igh-risk HCM patients, their absence more reliably de-
ned those patients at low risk who deserve reassurance
egarding their prognosis.
tudy limitations. Since this is a retrospective clinical
nvestigation, we acknowledge the possibility of some pa-
ient selection bias. On the other hand, the low annual
udden death rate in our cohort suggests that the selection
f HCM patients for Holter ECG probably did not
nfluence our findings substantially. For example, compari-
on of those 178 study patients with a Holter ECG to 118
CM patients without a Holter ECG (who were not
nalyzed as part of the primary study population) with
espect to demographic, clinical, echocardiographic, and
utcome variables revealed no measurable differences with
he exception of somewhat younger age and slightly in-
reased left atrial size in the Holter group. Sudden death
ate was 1.1% per year for patients with Holter ECG versus
.0% without Holter ECG. Also, very young patients and
hose of advanced age may have been underrepresented in
ur study population, thereby reducing the power of gen-
ralizing our findings to HCM patients in these age groups.
n addition, due to clinical care considerations, it was not
ossible to routinely withdraw patients from obligatory
ardioactive medications before obtaining the Holter re-
ordings. Nevertheless, we found no differences in arrhyth-
ia frequency between those patients with or without drug
herapy. Finally, the low incidence of sudden death may
ave influenced our sensitivity and predictive value calcula-
ions and reduced the power to detect a significant relation-
hip between arrhythmias on Holter and outcome.
In conclusion, in our nontertiary-based population,
1CM was associated with a particularly high frequency of a
ide variety of ventricular and supraventricular tachyar-
hythmias on ambulatory (Holter) ECG. Nevertheless,
udden death events proved to be relatively uncommon and
requent and/or complex ventricular arrhythmias had low
ositive but relatively high negative predictive value for
CM-related sudden death. Although the power of the
olter ECG in reliably assessing prognosis appears to vary
mong different HCM cohorts, based on the available data
including those presented here), it has sufficient clinical
alue to merit a continuing routine role in the outpatient
valuation of HCM patients.
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